Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Charles River Labs (CRL) and Neurocrine (NBIX)
TipRanksMay 1 20:19
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278
MT NewswiresApr 12 22:20
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating
MT NewswiresMar 22 23:38
Charles River Analyst Ratings
BenzingaMar 19 01:40
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating
MT NewswiresFeb 16 20:50
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Charles River Labs (CRL) and Shockwave Medical (SWAV)
TipRanksFeb 16 20:20
Evercore ISI Remains a Buy on Charles River Labs (CRL)
TipRanksFeb 16 08:25
Baird Adjusts Price Target on Charles River Laboratories International to $268 From $252, Maintains Outperform Rating
MT NewswiresFeb 15 23:23
Charles River Analyst Ratings
BenzingaFeb 15 21:01
Charles River Labs: A Cautious Hold Amidst Anticipated Second-Half Recovery
TipRanksFeb 15 19:18
Charles River Analyst Ratings
BenzingaDec 21, 2023 03:55
UBS Adjusts Charles River Laboratories International Price Target to $270 From $215, Maintains Buy Rating
MT NewswiresDec 15, 2023 23:57
Charles River Analyst Ratings
BenzingaDec 11, 2023 20:02
Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), HCA Healthcare (HCA) and Becton Dickinson (BDX)
TipRanksNov 11, 2023 12:20
Morgan Stanley Maintains Equal-Weight on Charles River, Lowers Price Target to $205
BenzingaNov 10, 2023 21:54
Analysts Have Conflicting Sentiments on These Healthcare Companies: Charles River Labs (CRL) and Stryker (SYK)
TipRanksNov 10, 2023 17:20
Charles River Labs (CRL) Gets a Hold From TD Cowen
TipRanksNov 10, 2023 06:18
UBS Maintains Buy on Charles River, Lowers Price Target to $215
BenzingaNov 10, 2023 03:50
Charles River Analyst Ratings
BenzingaNov 10, 2023 03:48
Deutsche Bank Adjusts Charles River Laboratories International Price Target to $215 From $236, Maintains Buy Rating
MT NewswiresNov 10, 2023 00:36
No Data
No Data